The importance of written information packages in support of case-finding within families at risk for inherited high cholesterol

Journal of Genetic Counseling

Volumn 15, Issue 1, 2006, Pages 29-40

  Van Den Nieuwenhoff, Hélène W P ^a   Mesters, Ilse ^a   Nellissen, Joyce J T M ^a   Stalenhoef, Anton F ^b   De Vries, Nanne K ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brochures; Disclosure; Familial combined hyperlipidemia; Familial hypercholesterolemia; Family relations; Genetic counseling; Genetic screening; Patient education; Qualitative evaluation

Indexed keywords

ADULT; AGED; ARTICLE; CASE FINDING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CULTURAL FACTOR; EVALUATION; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY RELATION; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; INTERPERSONAL COMMUNICATION; MALE; NETHERLANDS; PATIENT EDUCATION; PATIENT INFORMATION; QUALITATIVE DIAGNOSIS; RELATIVE; WRITTEN LANGUAGE;

ADULT; AGED; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INTERVIEWS; MIDDLE AGED; PATIENT EDUCATION;

EID: 33646460110     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-005-9001-8     Document Type: Article

References (54)

1. Andersen, L. K., Jensen, H. K., Juul, S., & Faergeman, O. (1997). Patients' attitudes toward detection of heterozygous familial hypercholesterolemia. Arch Intern Med, 157(5), 553-560.
2. Arthur, V. A. R. (1995). Written patient information: A review of the literature. J Adv Nurs, 21, 1081-1086.
3. Athyros, V. G., Papageorgiou, A. A., Hatzikonstandinou, H. A., Didangelos, T. P., Carina, M. V., Kranitsas, D. F., et al. (1997). Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia. Am J Cardiol, 80(5), 608-613.
4. Austin, M. A., Zimmern, R. L., & Humphries, S. E. (2002). High "population attributable fraction" for coronary heart disease mortality among relatives in monogenic familial hypercholesterolemia. Genet Med, 4(4), 275-278.
5. Ayres, L., Kavanaugh, K., & Knafl, K. A. (2003). Within-case and across-case approaches to qualitative data analysis. Qual Health Res, 13(6), 871-883.
6. Baker, D. L., Each, T., Schuette, J. L., & Uhlmann, W. R. (2002). Guidelines for writing letters to patients. J Genet Couns, 11(5), 399-418.
7. Baum, A., Friedman, A. L., & Zakowski, S. G. (1997). Stress and genetic testing for disease risk. Health Psychol, 16(1), 8-19.
8. Blandy, C., Chabal, F., Stoppa-Lyonnet, D., & Julian-Reynier, C. (2003). Testing participation in BRCA1/2-positive families: Initiator role of index cases. Genet Test, 7(3), 225-233.
9. Charnock, D., Shepperd, S., Needham, G., & Gann, R. (1999). DISCERN: An instrument for judging the quality of written consumer health information on treatment choices. J Epidemiol Community Health, 53, 105-111.
10. Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet, 116(1), 11-19.
11. Cope, C. D., Lyons, A. C., Donovan, V., Rylance, M., & Kilby, M. D. (2003). Providing letters and audiotapes to supplement a prenatal diagnostic consultation: Effects on later distress and recall. Prenat Diagn, 23(13), 1060-1067.
12. Coulter, A., Entwistle, V., & Gilbert, D. (1998). Patients' views on information and involvement. In A. Coulter, V. Entwistle, & D. Gilbert (Eds.), Informing patients: An assessment of the quality of patient information materials (pp. 25-36). London: King's Fund.
13. Daly, M. B., Barsevick, A., Miller, S. M., Buckman, R., Costalas, J., Montgomery, S., et al. (2001). Communicating genetic test results to the family: A six-step, skills-building strategy. Fam Community Health, 24(3), 13-26.
14. De Jong, M. (1998). Reader feedback in text design: Validity of the plus-minus method for the pretesting of public information brochures. Amsterdam: Rodopi.
15. Eaden, J. A., Ward, B., & Mayberry, J. F. (1998). Providing letters to patients. Letters should be used carefully. BMJ, 316(7147), 1831.
16. Emery, J., Kumar, S., & Smith, H. (1998). Patient understanding of genetic principles and their expectations of genetic services within the NHS: A qulitative study. Community Genet, 1, 78-83.
17. Finch, J., & Mason, J. (1993). Negotiating family responsibilities. London: Tavistock/Routledge.
18. Forrest, K., Simpson, S. A., Wilson, B. J., van Teijlingen, E. R., McKee, L., Haites, N., et al. (2003). To tell or not to tell: Barriers and facilitators in family communication about genetic risk. Clin Genet, 64, 317-326.
19. Goldstein, J. L., Hobbs, H. H., & Brown, M. S. (2001). Familial hypercholesterolaemia. In C. R. Scriver, A. L. Beaudet, W. S. Sly, & D. Vale (Eds.). The metabolic and molecular basis of inherited disease, (vol. II pp. 2863-2914). New York: McGraw-Hill.
20. Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973). Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest, 52, 1544-1568.
21. Goode, W. J. (1963). World revolution and family patterns. New York: Free.
22. Green, N., Britt, T., & Jirak, K. (2004). Communication of uncertainty in clinical genetics patient health communication systems. In Paper American Association for Artificial Intelligence (AAAI) Fall Symposium on Dialogue Systems for Health Communication, Arlington, Virginia, October 21-24, 2004. Retrieved March 10, 2005, from http://www.misu.bmc.org/~bickmore/dshc/ green-uncertainty.pdf.
23. Hallowell, N., & Murton, F. (1998). The value of written summaries of genetic consultations. Patient Educ Couns, 35(1), 27-34.
24. Hopkins, P. N. (2003). Familial hypercholesterolemia - Improving treatment and meeting guidelines. Int J Cardiol, 89(1), 13-23.
25. Illingworth, D. R., Duell, P. B., & Connor, W. E. (1995). Disorders of lipid metabolism. In P. Felig, J. D. Baxter, & A. Frohman (Eds.), Endocrinology and metabolism (pp. 1315-1405). New York: McGraw-Hill.
26. Julian-Reynier, C., Eisinger, F., Chabal, F., Aurran, Y., Bignon, Y. J., Nogues, C., et al. (1998). Cancer genetic clinics: Why do women who already have cancer attend? Eur J Cancer, 34(10), 1549-1553.
27. Julian-Reynier, C., Eisinger, F., Vennin, P., Chabal, F., Aurran, Y., Nogues, C., et al. (1996). Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet, 33, 731-736.
28. Kahneman, D., Slovic, P., & Tversky, A. (1982). Judgment under uncertainty: Heuristics and biases. Cambridge: Cambridge University Press.
29. Kenny, T., Wilson, R. G., Purves, I. N., Clark, J., Newton, L. D., Newton, D. P., et al. (1998). A PIL for every ill? Patient information leaflets (PILs): A review of past, present and future use. Fam Pract, 15(5), 471-479.
30. Lehmann, L. S., Weeks, J. C., Klar, N., Biener, L., & Garber, J. E. (2000). Disclosure of familial genetic information: Perceptions of the duty to inform. Am J Med, 109(9), 705-711.
31. Lerman, C., Daly, M., Masny, A., & Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol, 12(4), 843-850.
32. Lerman, C., Seay, J., Balshem, A., & Audrain, J. (1995). Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet, 57, 385-392.
33. McGivern, M. S., Everett, J., Yager, G. G., Baumiller, R. C., Hafertepen, A., & Saal, H. M. (2004). Family communication about positive BRCA1 and BRCA2 genetic test results. Genet Med, 6(6), 503-509.
34. Mesters, I., Ausems, M., Eichhorn, S., & Vasen, H. (2005). Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): A retrospective exploratory study. Fam Cancer, 4(2), 163-167.
35. Michie, S., di Lorenzo, E., Lane, R., Armstrong, K., & Sanderson, S. (2004). Genetic information leaflets: Influencing attitudes towards genetic testing. Genet Med, 6(4), 219-225.
36. Neil, H. A. W., Hammond, T., Huxley, R., Matthews, D. R., & Humphries, S. E. (2000). BMJ, 321, 148.
37. NIDI (Nederlands Interdisciplinair Demografisch Instituut). (2004). Familiebanden belicht: Eerste resultaten NKPS-onderzoek bekend. [First results of NKPS-research known.] Demos, 20(10), 73. Retrieved June 6, 2005, from http://www.nkps.nl/NKPSNL/nkps.htm.
38. NKPS (Netherlands Kinship Panel Study). (2000). Family relationships: The ties that bind. A sociological and demographic research programme 2000-2006. Retrieved June 6, 2005, from http://www.nkps.nl/Downloads/TiesThatBind.pdf.
39. Nuffield Council on Bioethics. (1993). Genetic screening: Ethical Issues. London: Nuffield Council on Bioethics. Retrieved March 3, 2005, from http://www.nuffieldbioethics.org/fileLibrary/pdf/genetic_screening.pdf.
40. Peterson, S. K., Watts, B. G., Koehly, L. M., Vernon, S. W., Baile, W. F., Kohlmann, W. K., et al. (2003). How families communicate about HNPCC genetic testing: Findings from a qualitative study. Am J Med Genet, 119C(1), 78-86.
41. Pope, C., Ziebland, S., & Mays, N. (2000). Qualitative research in health care: Analysing qualitative data. BMJ, 320, 114-116.
42. Rader, D. J., Cohen, J., & Hobbs, H. H. (2003). Monogenic hypercholesterolemia: New insights in pathogenesis and treatment. J Clin Invest, 111(12), 1795-1803.
43. Raynor, D. K. (1998). The influence of written information on patient knowledge and adherence to treatment. In L. B. Myers & K. Midence (Eds.), Adherence to treatment in medical conditions (pp. 83-111). London: Harwood Academic.
44. Rispens, J., Hermanns, J. M. A., & Meeus, W. H. J. (Eds.). (1996). Opvoeden in Nederland. [Parenting in the Netherlands.] Assen: Van Gorcum.
45. Scientific Steering Committee on behalf of the Simon Broome Register Group. (1991). Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ, 303(6807), 893-896.
46. Scientific Steering Committee on behalf of the Simon Broome Register Group. (1999). Mortality in treated heterozygous familial hypercholesterolaemia. Atherosclerosis, 142, 105-112.
47. Sorenson, J. R., Jennings-Grant, T., & Newman, J. (2003). Communication about carrier testing within hemophilia A families. Am J Med Genet, 119C(1), 3-10.
48. Starbuck, G. H. (2001). Is there a post-industrial family form? An exploration using global data. 43rd Annual Conference of the Western Social Science Association. Retrieved June 6, 2005, from http://home.mesastate.edu/ ~starbuck/pifamfrm.pdf.
49. Thompson, H. S., Wahl, E., Fatone, A., Brown, K., Kwate, N. O., & Valdimarsdottir, H. (2004). Enhancing the readability of materials describing genetic risk for breast cancer. Cancer Control, 11(4), 245-253.
50. Veerkamp, M. J., de Graaf, J., Hendriks, J. C., Demacker, P. N., & Stalenhoef, A. F. (2004). Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Circulation, 109(24), 2980-2985.
51. Wagner Costalas, J., Itzen, M., Malick, J., Babb, J. S., Bove, B., Godwin, A. K., et al. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: A cancer risk assessment program's experience. Am J Med Genet, 119C(1), 11-18.
52. Wilcke, J. T. (1998). Late onset genetic disease: Where ignorance is bliss, is it folly to inform relatives? BMJ, 317(7160), 744-747.
53. Wilson, B. J., Forrest, K., van Teijlingen, E. R., McKee, L., Haites, N., Matthews, E., et al. (2004). Family communication about genetic risk: The little that is known. Community Genet, 7(1), 15-24.
54. Wroe, A. L., Salkovskis, P. M., & Rimes, K. A. (1998). The prospect of predictive testing for personal risk: Attitudes and decision making. Behav Res Ther, 36(6), 599-619.